Study: Falls rate nearly 50% for U.S. seniors with dementia; 3 factors raise risk
By
Alicia Lasek
Jan 13, 2023
Nearly half of American seniors with dementia had one or more falls in the preceding year, according to a new analysis of 2016 data. Risk factors differed between seniors with and without dementia, investigators...
Most ‘long COVID’ symptoms resolve within a year, national study finds
By
Alicia Lasek
Jan 13, 2023
Patients who recover from mild COVID-19 are at risk for health issues tied to long COVID. Most of these problems resolve with a year — at least for those aged 60 and younger, a new study has found.
Tap water is not sterile for use in medical devices; many people unaware, CDC finds
Jan 13, 2023
Large numbers of Americans mistakenly believe that tap water is safe for use in home medical devices such as CPAP machines, a CDC survey reveals.
Skilled nursing deals led record year for seniors housing and care
By
Kimberly Marselas
Jan 12, 2023
The number of publicly announced seniors housing and care acquisitions rose to 527 in 2022, and skilled nursing powerhouse pacts sent the average amounts soaring.
Kramer named McKnight’s Pinnacle Career Achievement Award winner
By
James M. Berklan
Jan 11, 2023
Robert G. Kramer, the entrepreneurial thought leader who created a forum for investors in long-term care and revolutionized the use of data in the space, has been chosen as the 2023 Career Achievement...
Also in the News for Wednesday, Jan. 11
By
Kimberly Marselas
Jan 11, 2023
Public Health Emergency extension — possibly the last — expected this week … Washington hospitals advocate for increased LTC funding as Legislature opens … California long-term care insurance task...
It takes a (winter) village…
By
Foster Stubbs
Jan 10, 2023
Ed Templin has lived all over the place in his life. Originally from Kentucky, he also called Illinois, Maryland and Arizona home before settling in Ohio, where he has lived since 1954. Being the son of...
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
As Medicare Advantage threats mount, providers seek better partners: 2023 Outlook Survey
By
Kimberly Marselas
Jan 06, 2023
More skilled nursing providers are embracing Institutional Special Needs Plans by joining existing programs or creating their own as enrollment in other Medicare Advantage plans surpass half of all Medicare...
Peer messaging tool tackles workplace behavior, shows success in nurse study
By
Alicia Lasek
Jan 06, 2023
The CORS tool allows behavior to be anonymously reported and addressed by a trained peer, without involving nursing leadership or human resources unless necessary.